Cardiovascular Diseases

Family History of Heart Disease Still Matters

A cross-sectional analysis suggested that a multivariable model of clinical and genetic risk factors explains only 36% of the likelihood of family history of heart disease (FHHD), with most of the risk of a FHHD unexplained. The analysis included 166,714 UK Biobank participants with 43.2% reported a FHHD. In the multivariable model, polygenic risk score for coronary artery disease (PRSCAD, OR 1.30), and heterozygous familial hypercholesterolemia (HeFH, OR 1.31) were most strongly associated with FHHD, followed by clinical risk factors: hypertension (OR 1.18), lipoprotein(a) (OR 1.17), apolipoprotein B-to-apolipoprotein A1 ratio, (OR 1.13) and triglycerides (OR 1.07). Population attributable risks analyses showed that 21.9% of the risk of reporting a FHHD is attributed to clinical factors, 22.2% is attributed to genetic factors, and 36.0% is attributed to genetic and clinical factors combined. The findings suggest that much of the self-reported FHHD is not explained by currently available genetic and clinical biomarkers and implies knowledge gap. Source: https://academic.oup.com/

hyangiu

Recent Posts

Global Study of Stroke Risk Factors

A study revealed that stroke remains a major global health challenge, influenced by numerous risk…

2 days ago

Antidepressants Effective and Safe in Older Adults with Anxiety

A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…

3 days ago

Geographical Variation in Lipoprotein (a) Levels Among CHD Patients

A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…

2 weeks ago

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

3 weeks ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 weeks ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 month ago

This website uses cookies.